Non-invasive electrode stimulation gives hope to spinal cord injury patients with partial paralysis
Mr Reuben T. Sreetharan, who injured his spinal cord in the middle back in 2024, was the first participant in the electrode stimulation trial. ST PHOTO: SHINTARO TAY
SINGAPORE – Last year, while clearing debris from the Moringa tree in his backyard, Mr Reuben T. Sreetharan fell, landing hard on his feet before collapsing into a seated position. There was no pain, but he couldn't move his legs.
At the hospital, the 53-year-old businessman learnt that the fall had injured his spinal cord in the middle back, which partially severed his brain's connection to the body from below that area. His hospital stay lasted five months, during which he had to learn how to live without the use of his lower body.
In Singapore, the National Neuroscience Institute (NNI) and Tan Tock Seng Hospital (TTSH) have previously said they see approximately 100 new cases of spinal cord injury (SCI) annually, while the hospitals in the National University Health System cluster manage an average of 35 new inpatient cases every year.
Falls are a leading cause of this life-altering condition, especially in older adults, who may be at an increased risk of premature death due to injury-related complications.
There is no known cure for SCI, which results in either complete or incomplete loss of sensory and/or motor functions below the injury level, but researchers around the world and here are exploring new treatments, including therapies and advanced assistive technologies.
A promising research area is electrode stimulation, which involves delivering electrical pulses either through electrodes placed on the skin known as transcutaneous spinal cord stimulation, or surgically implanted near the spinal cord.
At Alexandra Hospital (AH), Clinical Assistant Professor Gobinathan Chandran, a consultant in rehabilitation medicine, started a new trial that uses non-invasive electrode stimulation with robotic gait training to enhance mobility in SCI patients.
In November 2024, Mr Sreetharan became the first of six participants in the trial, and underwent 32 sessions of therapy using a wearable robotic device that supports and assists movement known as the exoskeleton, including 16 done with electrode stimulation.
It was not till the 25th session that he started to notice subtle changes. He said he can now feel his feet pressing on the footrests of his wheelchair, his hamstrings, and even his glutes, when previously he felt like he was living on a cloud.
Mr Sreetharan is hoping the therapy can become a clinical service, as Dr Chandran had said that overseas studies done on the use of non-invasive electrical stimulation for upper limb mobility showed that at least 60 sessions are needed to show sustained functional improvements.
'I would say that, frankly, I've not given up. I think that's what keeps me going,' he said.
So far, early results from the trial are promising – participants were able to take more steps per minute with the stimulation when using a robotic wearable device to assist with the walking, and this led to improved walking speed, said Dr Chandran.
'Those who are severely injured might not be able to walk at the end of the day, but if they're able to improve their truncal control, are better in transferring on their own and all that, these are small things that really will improve their quality of life,' he told The Straits Times .
'If they're already a walker, then we want them to walk with a better gait, or even independently.'
Mr Reuben T. Sreetharan can now feel his feet pressing on the footrests of his wheelchair, his hamstrings, and even his glutes, when previously he felt like he was living on a cloud.
ST PHOTO: SHINTARO TAY
AH has recruited four patients for the first study of six patients funded by a NUHS $150,000 seed grant and one patient for the second study of six patients with partial paralysis of four limbs. As there is no grant for the latter, participants have to pay $180 for the physiotherapy for each session.
The trials are for patients who were diagnosed with a traumatic and incomplete SCI between six months and five years ago and cannot walk independently.
Dr Chandran said the aim is to use electrodes to stimulate the surviving dormant nerves of patients with an incomplete injury to improve their functional mobility.
Likening the spinal cord to an expressway, where an accident there would result in a traffic jam, he said the treatment is assumed to work by helping to widen the road a bit to let more cars go through.
'The brain signals can then easily go through the area, because you have now managed to augment the signalling around the area,' he said.
The loaned device used in AH's trials is the ARC-EX system from ONWARD Medical. The firm's global clinical trial for the therapy, the results of which were published in the Nature Medicine journal in 2024, had found that 72 per cent of the 60 study participants who completed the trial demonstrated improvement in both strength and function.
It came in late 2024, nearly three years after Dr Chandran and Adjunct Associate Professor Effie Chew, AH's head of the division of rehabilitation medicine, made a field trip in 2022 to the Reade rehabilitation hospital in Amsterdam – one of the sites in the trial done across the United States, Europe, and Canada – to learn about this new device and observe its use on patients.
The loaned device used in Alexandra Hospital's trials is the ARC-EX system from ONWARD Medical.
ST PHOTO: SHINTARO TAY
In a statement released through AH, ONWARD Medical CEO Dave Marver said that it was excited to support the study, the first of its kind in Singapore and Asia, as they work on expanding access to their technologies globally.
'The preliminary results reported by Dr Gobinathan Chandran and his team validate what we have seen in other regions – that ARC-EX Therapy, when combined with physical therapy, can enable meaningful improvements for people living with spinal cord injuries,' he said.
Meanwhile, AH has also just received ethics approval to study the use of non-invasive electrode stimulation in 16 SCI patients with upper-limb functional impairments.
Elsewhere in Singapore, there is another trial studying the use of surgically-implanted electrode near the spinal cord to restore motion for patients with complete spinal cord injuries. The Restores (restoration of rehabilitative function with epidural spinal stimulation) clinical trial is conducted by NNI, TTSH and A*Star.
It has completed the first phase, with three patients, and is moving into the second phase, with 15 patients, later this year.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
13-06-2025
- Straits Times
Non-invasive electrode stimulation gives hope to spinal cord injury patients with partial paralysis
Mr Reuben T. Sreetharan, who injured his spinal cord in the middle back in 2024, was the first participant in the electrode stimulation trial. ST PHOTO: SHINTARO TAY SINGAPORE – Last year, while clearing debris from the Moringa tree in his backyard, Mr Reuben T. Sreetharan fell, landing hard on his feet before collapsing into a seated position. There was no pain, but he couldn't move his legs. At the hospital, the 53-year-old businessman learnt that the fall had injured his spinal cord in the middle back, which partially severed his brain's connection to the body from below that area. His hospital stay lasted five months, during which he had to learn how to live without the use of his lower body. In Singapore, the National Neuroscience Institute (NNI) and Tan Tock Seng Hospital (TTSH) have previously said they see approximately 100 new cases of spinal cord injury (SCI) annually, while the hospitals in the National University Health System cluster manage an average of 35 new inpatient cases every year. Falls are a leading cause of this life-altering condition, especially in older adults, who may be at an increased risk of premature death due to injury-related complications. There is no known cure for SCI, which results in either complete or incomplete loss of sensory and/or motor functions below the injury level, but researchers around the world and here are exploring new treatments, including therapies and advanced assistive technologies. A promising research area is electrode stimulation, which involves delivering electrical pulses either through electrodes placed on the skin known as transcutaneous spinal cord stimulation, or surgically implanted near the spinal cord. At Alexandra Hospital (AH), Clinical Assistant Professor Gobinathan Chandran, a consultant in rehabilitation medicine, started a new trial that uses non-invasive electrode stimulation with robotic gait training to enhance mobility in SCI patients. In November 2024, Mr Sreetharan became the first of six participants in the trial, and underwent 32 sessions of therapy using a wearable robotic device that supports and assists movement known as the exoskeleton, including 16 done with electrode stimulation. It was not till the 25th session that he started to notice subtle changes. He said he can now feel his feet pressing on the footrests of his wheelchair, his hamstrings, and even his glutes, when previously he felt like he was living on a cloud. Mr Sreetharan is hoping the therapy can become a clinical service, as Dr Chandran had said that overseas studies done on the use of non-invasive electrical stimulation for upper limb mobility showed that at least 60 sessions are needed to show sustained functional improvements. 'I would say that, frankly, I've not given up. I think that's what keeps me going,' he said. So far, early results from the trial are promising – participants were able to take more steps per minute with the stimulation when using a robotic wearable device to assist with the walking, and this led to improved walking speed, said Dr Chandran. 'Those who are severely injured might not be able to walk at the end of the day, but if they're able to improve their truncal control, are better in transferring on their own and all that, these are small things that really will improve their quality of life,' he told The Straits Times . 'If they're already a walker, then we want them to walk with a better gait, or even independently.' Mr Reuben T. Sreetharan can now feel his feet pressing on the footrests of his wheelchair, his hamstrings, and even his glutes, when previously he felt like he was living on a cloud. ST PHOTO: SHINTARO TAY AH has recruited four patients for the first study of six patients funded by a NUHS $150,000 seed grant and one patient for the second study of six patients with partial paralysis of four limbs. As there is no grant for the latter, participants have to pay $180 for the physiotherapy for each session. The trials are for patients who were diagnosed with a traumatic and incomplete SCI between six months and five years ago and cannot walk independently. Dr Chandran said the aim is to use electrodes to stimulate the surviving dormant nerves of patients with an incomplete injury to improve their functional mobility. Likening the spinal cord to an expressway, where an accident there would result in a traffic jam, he said the treatment is assumed to work by helping to widen the road a bit to let more cars go through. 'The brain signals can then easily go through the area, because you have now managed to augment the signalling around the area,' he said. The loaned device used in AH's trials is the ARC-EX system from ONWARD Medical. The firm's global clinical trial for the therapy, the results of which were published in the Nature Medicine journal in 2024, had found that 72 per cent of the 60 study participants who completed the trial demonstrated improvement in both strength and function. It came in late 2024, nearly three years after Dr Chandran and Adjunct Associate Professor Effie Chew, AH's head of the division of rehabilitation medicine, made a field trip in 2022 to the Reade rehabilitation hospital in Amsterdam – one of the sites in the trial done across the United States, Europe, and Canada – to learn about this new device and observe its use on patients. The loaned device used in Alexandra Hospital's trials is the ARC-EX system from ONWARD Medical. ST PHOTO: SHINTARO TAY In a statement released through AH, ONWARD Medical CEO Dave Marver said that it was excited to support the study, the first of its kind in Singapore and Asia, as they work on expanding access to their technologies globally. 'The preliminary results reported by Dr Gobinathan Chandran and his team validate what we have seen in other regions – that ARC-EX Therapy, when combined with physical therapy, can enable meaningful improvements for people living with spinal cord injuries,' he said. Meanwhile, AH has also just received ethics approval to study the use of non-invasive electrode stimulation in 16 SCI patients with upper-limb functional impairments. Elsewhere in Singapore, there is another trial studying the use of surgically-implanted electrode near the spinal cord to restore motion for patients with complete spinal cord injuries. The Restores (restoration of rehabilitative function with epidural spinal stimulation) clinical trial is conducted by NNI, TTSH and A*Star. It has completed the first phase, with three patients, and is moving into the second phase, with 15 patients, later this year. Join ST's WhatsApp Channel and get the latest news and must-reads.
Straits Times
13-06-2025
- Straits Times
More studies being done to help Singapore residents take charge of their health
More studies being done to help Singapore residents take charge of their health SINGAPORE – In Toa Payoh, surveyors are making house visits, spending up to 45 mins in each home to gather information about residents' health and lifestyles. The questions range from what they do for a living to how many friends and relatives they connect with at least once a month and whether they have caregiving responsibilities. All the answers feed into a five-year research programme aimed at improving residents' health outcomes. The Health4All@Toa Payoh study by the Department of Epidemiology and Preventive Medicine at Tan Tock Seng Hospital (TTSH) was launched in March 2025. It has recruited about half of its target of 4,000 participants aged between 35 and 70 years. In this longitudinal study, participants – Singapore citizens or Permanent Residents residing in Toa Payoh – will be followed over five years through annual online surveys. Interviews and focus group discussions will also be held with groups of participants. Researchers want to understand how non-medical factors, such as daily activities, social networks, and living environments, affect the residents' health. Such factors, known as the social determinants of health, are widely believed to contribute to 80 per cent of health outcomes, while medical care accounts for an estimated 20 per cent. The data collected will be used to design personalised health solutions for residents. The study comes as Singapore pivots from traditional patient-centred care to a resident-centred approach. This is to help the population take charge of their health so that they can spend more years in good health as they age. A key move was in July 2023 when Singapore launched Healthier SG to get residents to enrol with a family doctor and focus on preventive care. Professor Teo Yik Ying, vice-president for global health and dean of the Saw Swee Hock School of Public Health at NUS, described Healthier SG as the first major reform of Singapore's health system. Rather than focusing solely on treating the sick, the programme aims to help the population stay healthy. But designing solutions to achieve that goal – which could include getting the community to form online networks – requires a deeper understanding of people's lives, said Associate Professor Angela Chow, the programme director of Health4All@Toa Payoh. What is lacking now is the understanding of how and what type of social networks influence health, said the senior consultant at TTSH's Department of Epidemiology and Preventive Medicine. 'How can we leverage our social networks to help us improve our health, and especially using community resources to do that?' she said. Her department head, Adjunct Assistant Professor Lim Wei-Yen, who is also the study's principal investigator , noted that many health studies capture only traditional risk factors such as physical activity, diet and smoking. However, people's lived environments, life circumstances, and social networks can shape not only their health behaviours but also their health literacy, he said. Knowing how significant life events like bereavement or divorce can influence a person's well-being and health will enable the team to find ways of supporting residents and identify opportunities for early intervention, he added. TTSH is part of the National Healthcare Group (NHG), one of the three clusters that manage Singapore's public healthcare system. Prof Chow said the lessons gleaned from various studies of different population groups in Singapore are meant to be shared across the healthcare clusters so that successful strategies in one region can be scaled up and tested in other areas. If another research team discover an effective approach, the NHG team would also want to see how they can pilot it for the population under their care, she said. Each of the three healthcare clusters covers a specific geographic area. The central region is managed by NHG, the western region by the National University Health System (NUHS), and the eastern region by Singapore Health Services (SingHealth). Each cluster – expected to look after up to 1.5 million people – gets paid for each resident, regardless of whether the person is healthy or not. At SingHealth, its population health research include an ongoing four-year study to understand residents' sentiments on the various aspects of Healthier SG, with the goal of improving its implementation. In 2023, some 5,000 participants around Singapore were asked about their beliefs and attitudes towards enrolling in Healthier SG and their expectations. SingHealth then surveyed another group of more than 2,000 participants in the eastern region in 2024 about their enrolment status and their experience with Healthier SG. A key finding was that residents were unsure about the community resources that their general practitioners (GPs) can refer them to, said Associate Professor Low Liang Leng, director of the SingHealth Centre for Population Health Research and Implementation (CPHRI). 'Our community nurses and well-being coordinators now work with the GPs so that they can refer their patients to us, and we will help them to navigate the community services required,' he added. SingHealth plans to continue engaging different groups to understand their views on other aspects of Healthier SG. In the west, NUS is conducting the second phase of the Baseline Study for Health District @ Queenstown to evaluate new factors such as financial literacy and caregiving. The study's first phase, completed in the first half of 2024, involved over 5,000 Queenstown residents aged 21 to 102 years old. It discovered that about two-thirds of the respondents above 65 years old did not actively participate in activities such as exercising, volunteering and learning, among other findings. A range of initiatives and programmes have been introduced in Queenstown since the health district pilot – spearheaded by NUS, NUHS and HDB – was launched in October 2021 to promote healthy longevity. A recent initiative was the Happy Village @ Mei Ling, a shared community space at Block 160 Mei Ling Street that officially opened in March. Residents can receive health counselling, join exercise classes and attend monthly health talks and workshops. With three healthcare clusters operating autonomously, there is bound to be some variations in their operations. A clear disadvantage of such a varied approach is the confusion it may cause for the average Singaporean, who may not be aware that some programmes are unique to specific clusters, said Prof Teo. However, the upside is that having a variety of programmes provides an opportunity for the country to test out different strategies to find out what works best, he said. A system is then needed to test and evaluate the different approaches – scaling those that are effective and discontinuing others that consistently underdeliver, he added. 'Health is multifaceted and affected by a range of factors, and it is not wrong that different clusters may prioritise different perspectives or determinants,' he said. 'However, we should ultimately have one single narrative of population health that Singapore wishes to have its people understand, and ensure the clusters conform to this.' Prof Teo said that Singapore is amongst the few countries in the world that are finding solutions to rapid demographic transitions and escalating healthcare costs. The goals of the healthcare clusters also align with Healthier SG's vision: fostering a healthier, more health-literate population within an environment that promotes healthy behaviours and improves overall health, he said. Join ST's WhatsApp Channel and get the latest news and must-reads.
Straits Times
01-06-2025
- Straits Times
S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial
Researchers involved in the project include (from left) Professor Lim Kah Leong, President's Chair in Translational Neuroscience at the Lee Kong Chian School of Medicine; Associate Professor Prakash Kumar, head and senior consultant at the department of neurology at the National Neuroscience Institute (NNI); Professor Louis Tan, NNI's director of research; and Professor Tan Eng King, NNI's deputy chief executive officer for academic affairs. ST PHOTO: NG SOR LUAN S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial SINGAPORE - Researchers from the National Neuroscience Institute (NNI) are embarking on a ground-breaking project to transplant stem cells into the brains of those with early Parkinson's disease, in a bid to stop the disease in its tracks. Planning for the first-of-its-kind trial in Singapore is still under way, pending regulatory and ethical approvals. Researchers are hopeful that the phase one trial for the novel approach can begin in late 2026, with five to eight patients who are younger and facing complications with their current treatments. The project is being funded under a $25 million research grant awarded on May 28 to the institute by the National Medical Research Council for five years to study Parkinson's disease. The programme is called Singapore Parkinson's Disease Programme, or Sparkle. An estimated 8,000 people in Singapore live with Parkinson's disease, which happens when dopamine-producing cells in the brain progressively die. As dopamine levels fall, patients present symptoms such as tremors and stiffness, and slowed movement appears. There is no known cure for the neurodegenerative disease, which leads to difficulty with walking, balance, coordination and even speech. The idea of replacing brain cells killed off by Parkinson's with stem cells has been around for about four decades. The hope is that the transplanted cells, which have the ability to evolve into different types of specialised cells, can then start producing dopamine, reversing the condition. But progress was held back by ethical considerations and technical hurdles. Professor Tan Eng King, principal investigator for Sparkle and NNI's deputy chief executive officer for academic affairs, said that in the past, stem cells from embryos and foetuses were used, raising ethical concerns . There were also mixed results, as some transplanted cells did not end up producing dopamine, and led to adverse side effects like involuntary limb movements. With advancements in cell therapies in recent years, scientists are now able to convert a patient's own normal body cells, such as skin or blood cells, into stem cells. Using a patient's own cells is a better approach as it reduces the risk of the body's immune system rejecting the transplanted cells. Prof Tan said NNI has collaborated with Duke-NUS Medical School, Lee Kong Chian School of Medicine and A*Star to develop a proprietary method of converting a person's normal cells into stem cells. The therapy is currently undergoing final approval by the US Food and Drug Administration before it can be used for the trial. He added that researchers from other countries are also studying similar stem cell approaches for Parkinson's disease. The most successful group will be the one 'that is able to create a stem cell source from using a patient's own cells that contains almost 100 per cent dopamine-producing cells and nothing else', said Prof Tan. 'This is a very challenging endeavour and it is not something that anybody can do. We have developed the expertise, and we think that potentially, we can be one of the pioneers,' he added. After the stem cells are transplanted, patients on the trial will likely be monitored for about two years to evaluate the safety and effectiveness of the approach. Other than the stem cell trial, another initiative under Sparkle is an early screening programme in the community to identify those at high risk of developing Parkinson's disease. Prof Tan said he is optimistic that the screening programme can be rolled out by the end of 2025, and reach 10,000 people over the age of 55 in the next three to five years. Currently, in Singapore, there is no screening available to detect those at risk of developing Parkinson's disease. But Prof Tan said that based on previous research done by NNI, those who suffer from a loss of sense of smell, have rapid eye movement sleep disorder (where people act out their dreams) and a particular gene variant have a higher chance of developing the disease. The screening will involve a questionnaire, after which those whose results warrant a closer look will be invited to go for more detailed examinations like brain scans. Those who are identified as having a high risk of developing the disease will be introduced to interventions, including making lifestyle changes in areas such as exercise and diet. Prof Tan pointed out that Singapore has one of the highest life expectancies in the world. 'If you can reduce the risk of developing a neurodegenerative condition, then you can increase the amount of years that you can spend in healthier living,' he said. Join ST's WhatsApp Channel and get the latest news and must-reads.
